Montreal and Charlotte, NC, May 8, 2019 — Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular...
Scott Weiner will moderate a discussion on the current IPO market at BIO International Convention 2013 in Chicago.
News | 04. 22. 2013
Scott Weiner will moderate a discussion on the current IPO market at BIO International Convention 2013 in Chicago.
